Biocon founder Kiran Mazumdar Shaw says India must shift pharma industry from generics to innovation-led growthKiran Mazumdar-Shaw emphasized the importance of building an innovation-driven pharmaceutical industry in India. She highlighted the need f...
13 Oct, 2026, 07.02 PM IST
Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-ShawBiocon chairperson Kiran Mazumdar-Shaw calls for greater use of digital technology to speed up drug development, as industry leaders push f...
11 Oct, 2026, 12.16 AM IST
Existential threats join bubble fears as AI mood sobers at Singapore forumsDuring conferences in Singapore, significant apprehensions regarding the dangers of artificial intelligence emerged among investors and pol...
07 Oct, 2026, 05.47 PM IST
Indian companies must invest in R&D, move from generics to innovation-led industry: Pharma leadersIndian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They high...
05 Oct, 2026, 05.59 PM IST
Bengaluru CEO spends Rs 2700 to fix broken footpath himself. IIT Madras alumnus says repeated complaints went unansweredBengaluru CEO and IIT Madras alumnus Siddharth Dialani took matters into his own hands to address a hazardous footpath that posed a risk to...
25 Sep, 2026, 12.39 PM IST
Kiran Mazumdar-Shaw has a career lesson from 3 Nobel prize winners as AI forces layoffs and changes jobs across the worldBiocon chairperson Kiran Mazumdar-Shaw shared a message on persistence from three 2023 Nobel Prize winners as AI reshapes jobs and companie...
22 Sep, 2026, 10.06 AM IST
Rs 8.3 lakh Fendi bag resembling 'Rs 500' Indian market designs: Why the luxury brand did not 'credit' Indian artisans, ask Harsh Goenka, Kiran Mazumdar-ShawFendi’s Rs 8.3 lakh multicolour bag, featuring 39,500 beads and 475 mirrors, has sparked an online debate over its resemblance to tradition...
16 Sep, 2026, 06.50 PM IST
ET Under 40 2026: How technology is creating younger leadersThe rise of technology is paving the way for younger Indians to step into leadership roles much earlier. Kiran Mazumdar-Shaw predicts that ...
16 Sep, 2026, 12.49 AM IST
ET 40 Under Forty: Meet the trailblazers of India’s tomorrowThe Economic Times 40 Under Forty awards honored young leaders shaping India's future. The event celebrated personal and professional achie...
15 Sep, 2026, 11.45 PM IST
Biocon shares: Active Pine may divest up to 1% equity worth Rs 638 crore via block dealActive Pine is likely to sell up to 1.66 crore Biocon shares, worth Rs 638 crore, through a block deal at Rs 385 per share. The development...
08 Sep, 2026, 07.49 PM IST
“Not Australia, but India rejected me for being a woman”: Kiran Mazumdar-Shaw clarifies how gender bias led her to build Biocon in viral postBiocon founder Kiran Mazumdar-Shaw intervened and clarified after a viral post claimed that Australia denied her a master brewer role due t...
30 May, 2026, 12.01 PM IST
The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
05 May, 2026, 05.35 PM IST
Hep C drugs will be a Rs 1,000-cr market; Cimivir-L will boost Biocon's virology biz: Kiran Mazumdar-Shaw"The market for Hepatitis C drugs is fairly large. There are high incidences of Hepatitis C in many parts of our country."
24 Dec, 2015, 11.20 AM IST
We need to augment focus on Asian partners: Kiran Mazumdar Shaw, Biocon"New govt is saying that they certainly want to have the West as strong partners, but we need to improve and augment our focus on our Asian...
26 Aug, 2014, 05.17 PM IST
Kiran Mazumdar-Shaw succeeds Mukesh Ambani as Chairperson of IIM-B boardWith this, Kiran Mazumdar-Shaw becomes the first woman chairperson of any IIM board in the country.
19 Feb, 2014, 04.59 AM IST
Looking for global partner for psoriasis drug: Kiran Mazumdar Shaw, BioconThe plan is that the India drug will launched as an intravenous infusion and it has been indicated for psoriasis, says Kiran Mazumdar Shaw.
08 Jan, 2013, 12.39 PM IST
- Biocon is at a strong price disadvantage to global players : Kiran Mazumdar Shaw
The National Pharmaceutical Pricing Authority has allowed pharma cos to increase the price of insulin drugs. Kiran Mazumdar Shaw, Chairpers...
29 Dec, 2010, 03.29 PM IST